PhenoBiome launches human gut microbiome assay with Genetic Direction
SAN FRANCISCO, Sept. 23, 2021 /PRNewswire/ -- PhenoBiome today announced it will launch its first human gut microbiome assay through Genetic Direction, a Dallas-based distributor of genetics-based health management programs. Clinical Enterprise, Inc., a Eurofins Scientific company, will process the assays in its CLIA- and CAP-certified laboratory.
The PhenoBiome test, GxGutHealth, will be available to patients on a non-exclusive basis through Genetic Direction's 900 health professional affiliates in the United States. The test provides a deeper level of understanding and insight into a patient's gut microbiome, by assessing important metabolic pathways and physiological properties that rely on the gut microbiome to thrive. The personalized and detailed reports can inform behavioral and other health interventions to help improve gut health.
"We know that the gut microbiome plays a key role in our overall health—from the digestive system to the immune system and from brain health to heart health," said Pavel Novichkov
Ph.D., co-founder and Chief Technology Officer of PhenoBiome. "Through more than a decade of research, our science team has identified the specific bacteria that contribute to more than 100 physiological functions in the human body, and built a test that provides a complete and accurate picture of an individual patient's gut microbiome." The test launched at the
Overcoming Obesity 2021 Conference in Chicago, this week.
In addition to the human test, PhenoBiome is also collaborating with one of the largest animal health companies in the world to apply human gut microbiome technology to animal health. That technology is expected to be available by late 2021.
The company has plans to expand into additional areas, including the development of personalized prebiotics, probiotics, and food supplements based on its gut health and microbiome analyses, a women's health gut and vaginal microbiome assay, and collaborations with therapeutic companies to leverage PhenoBiome testing in product development.
About Clinical Enterprise, Inc
About Eurofins Scientific – the global leader in bio-analysis
About Genetic Direction
Contact: Didier G. Perez
SOURCE PhenoBiome Inc